Boostrix 58160-0842
Generic: Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine, Adsorbed
Product NDC
58160-0842- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 24, 2009
- Listing Expires
- December 31, 2027
- Application
- BLA125106
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated) | 8 ug/.5mL |
| Bordetella Pertussis Pertactin Antigen (formaldehyde Inactivated) | 2.5 ug/.5mL |
| Bordetella Pertussis Toxoid Antigen (formaldehyde, Glutaraldehyde Inactivated) | 8 ug/.5mL |
| Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) | 5 [iU]/.5mL |
| Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated) | 2.5 [iU]/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Packaging Options(2)
10 VIAL in 1 CARTON (58160-842-11) / .5 mL in 1 VIAL (58160-842-01)
10 SYRINGE in 1 CARTON (58160-842-52) / .5 mL in 1 SYRINGE (58160-842-43)
Related Products
All Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine, Adsorbed NDC codes →External Resources